Scott A. Holmes, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 1,185 shares at $3.04 ($4K) on 2018-08-15, disclosed to the SEC on 2018-08-16.
Seasonal sale ($4k) by Chief Financial Officer — this insider has traded KERX in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KERX | SELL | 2018-07-31 | $9K | — | Filing → |
| KERX | SELL | 2018-05-16 | $7K | — | Filing → |
| KERX | SELL | 2018-05-01 | $11K | — | Filing → |